相关产品推荐更多 >

EZElisa™人半乳糖凝集素2(GAL2)ELISA试剂盒-EZElisa™ Human Galectin 2 (GAL2) ELISA Kit
询价
EZElisa™人Regucalcin(RGN)ELISA试剂盒-EZElisa™ Human Regucalcin (RGN) ELISA Kit
询价
EZElisa™分化簇30配体(CD30L)ELISA试剂盒-EZElisa™ Cluster Of Differentiation 30 Ligand (CD30L) ELISA Kit
询价
EZElisa ™ 人 Dachsous 2(DCHS 2)ELISA试剂盒-EZElisa™ Human Dachsous 2 (DCHS2) ELISA Kit
询价
EZElisa™ C型凝集素结构域家族4,成员A(CLEC4A)试剂盒-EZElisa™ C-Type Lectin Domain Family 4, Member A (CLEC4A) Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ VPS10 domain-containing receptor SorCS1 (SORCS1) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™ VPS10 domain containing receptor SorCS1(SORCS1)ELISA试剂盒,EZElisa™ VPS10 domain-containing receptor SorCS1 (SORCS1) ELISA Kit, VPS10 domain containing receptor SorCS1(SORCS1)ELISA试剂盒, VPS10 domain-containing receptor SorCS1 (SORCS1) ELISA Kit
产品名称:EZElisa™ Sonic hedgehog ELISA试剂盒-EZElisa™ VPS10 domain-containing receptor SorCS1 (SORCS1) ELISA Kit
产品货号:A-QEK05839-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of VPS10 domain - containing receptor SorCS1 (SORCS1) ELISA in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:78.125 - 5000 pg/ml

该EZElisa™ VPS10 domain containing receptor SorCS1(SORCS1)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™ Sonic hedgehog ELISA试剂盒-EZElisa™ VPS10 domain-containing receptor SorCS1 (SORCS1) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【信息】The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Review Nature Reviews Immunology 7, 353-364 (May 2007) | doi:10.1038/nri2079 The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling Luke A. J. O'Neill1 & Andrew G. Bowie1 About the authors Summary TLR (Toll
The binding of ligand to the extracellular domain of the epidermal growth factor (EGF) receptor is the event that initiates the activation of the tyrosine kinase activity present on the cytoplasmic domain. This activation leads
LMP2B EBV EBNA1 EBV EBNA2 EBV BZLF1 EBV BRLF1 EBV BcLF1 EBV BLLF1 HLA-DR alpha TNF-alpha supar-domain1 VEGF165 RP2 RP3 exon1 RP3 exon2 RP3 exon3~6 RP3 exon7~10 RP3 exon11~14 RP3 exon15~19 DYPD ICAM-I VCAM 1 BCL2L1 survivin
技术资料暂无技术资料 索取技术资料




